CVS Currently Up Eight Consecutive Days, on Track for Longest Winning Streak Since December 2021 — Data Talk
CVS Health Corporation (CVS) is currently at $61.28, up $0.34 or 0.56%
--Would be highest close since April 30, 2024, when it closed at $67.71
--Currently up eight consecutive days; up 14.26% over this period
--Longest winning streak since Dec. 13, 2021, when it rose for eight straight trading days
--Best eight day stretch since the eight days ending Nov. 16, 2020, when it rose 21.7%
--Up 2.82% month-to-date
--Down 22.39% year-to-date
--Down 45.99% from its all-time closing high of $113.45 on July 29, 2015
--Down 14.60% from 52 weeks ago (June 9, 2023), when it closed at $71.76
--Down 24.74% from its 52-week closing high of $81.42 on Jan. 5, 2024
--Up 14.26% from its 52-week closing low of $53.63 on May 28, 2024
--Traded as high as $61.50; highest intraday level since April 30, 2024, when it hit $68.18
--Up 0.92% at today's intraday high
All data as of 11:27:56 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 07, 2024 11:45 ET (15:45 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations